These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25548430)

  • 1. The CCR5Δ32 polymorphism in Brazilian patients with sickle cell disease.
    Lopes MP; Santos MN; Faber EW; Bezerra MA; Hatzlhofer BL; Albuquerque DM; Zaccariotto TR; Ribeiro DM; Araújo Ada S; Costa FF; Sonati Mde F
    Dis Markers; 2014; 2014():678246. PubMed ID: 25548430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia.
    Chies JA; Hutz MH
    Braz J Med Biol Res; 2003 Jan; 36(1):71-5. PubMed ID: 12532229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of HMOX1 and CCR5 genotypes on clinical phenotype of Egyptian patients with sickle cell anemia.
    Bakr S; Khorshied M; Talha N; Jaffer KY; Soliman N; Eid K; El-Ghamrawy M
    Ann Hematol; 2019 Aug; 98(8):1805-1812. PubMed ID: 31030250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.
    Baltus TH; Kallaur AP; Lozovoy MA; Morimoto HK; Delongui F; Alfieri DF; Iriyoda TM; Dichi I; Simão AN; Reiche EM
    Rheumatol Int; 2016 Jan; 36(1):7-15. PubMed ID: 26071874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease.
    Vargas AE; da Silva MA; Silla L; Chies JA
    Tissue Antigens; 2005 Dec; 66(6):683-90. PubMed ID: 16305685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the
    El Sissy MH; Hafez AA; Moneim SEA; Eldemerdash DM
    Hemoglobin; 2019; 43(4-5):258-263. PubMed ID: 31657666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CCR5Δ32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population.
    Maestri A; dos Santos MC; Ribeiro-Rodrigues EM; de Mello WA; Sousa RC; dos Santos SE; Sortica VA
    BMC Res Notes; 2015 Jul; 8():326. PubMed ID: 26223981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotypes and polymorphism in the CCR5 gene in sickle cell disease.
    Nascimento AF; Oliveira JS; Silva Junior JC; Barbosa AAL
    Genet Mol Res; 2017 Jun; 16(2):. PubMed ID: 28671257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CCR5Δ32 (rs333) polymorphism has no influence on severity and mortality of influenza A(H1N1)pdm09 infection in Brazilian patients from the post pandemic period.
    Matos AR; Martins JSCC; Oliveira MLA; Garcia CC; Siqueira MM
    Infect Genet Evol; 2019 Jan; 67():55-59. PubMed ID: 30389547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.
    Fatima F; Saleem S; Hameed A; Haider G; Ali Zaidi SA; Kanwal M; Zehra S; Azhar A
    Mol Biol Rep; 2019 Apr; 46(2):2387-2394. PubMed ID: 30848448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CCL5 and CCR5 gene polymorphisms with periodontitis in Taiwanese.
    Shih YS; Fu E; Fu MM; Lin FG; Chiu HC; Shen EC; Chiang CY
    J Periodontol; 2014 Nov; 85(11):1596-602. PubMed ID: 25119558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population.
    Kulmann-Leal B; Ellwanger JH; Chies JAB
    Front Immunol; 2021; 12():758358. PubMed ID: 34956188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Association between the CCR5Δ32 Polymorphism and Sporadic Esophageal Cancer in Punjab, North-West India.
    Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR; Singh H; Guleria K
    Asian Pac J Cancer Prev; 2015; 16(10):4291-5. PubMed ID: 26028088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease.
    Atzeni F; Boiardi L; Casali B; Farnetti E; Nicoli D; Sarzi-Puttini P; Pipitone N; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Filippini D; Paolazzi G; Salvarani C
    Rheumatology (Oxford); 2012 Dec; 51(12):2141-5. PubMed ID: 22966075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis.
    Lindner E; Nordang GB; Melum E; Flatø B; Selvaag AM; Thorsby E; Kvien TK; Førre OT; Lie BA
    BMC Med Genet; 2007 Jun; 8():33. PubMed ID: 17565662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR5Δ32 - A piece of protection in the inflammatory puzzle of multiple sclerosis susceptibility.
    Troncoso LL; Pontillo A; Oliveira EML; Finkelszteijn A; Schneider S; Chies JAB
    Hum Immunol; 2018 Aug; 79(8):621-626. PubMed ID: 29729320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
    Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
    Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary acute dengue and the deletion in chemokine receptor 5 (CCR5Δ32).
    Brestovac B; Halicki LA; Harris RP; Sampson I; Speers DJ; Mamotte C; Williams D
    Microbes Infect; 2014 Jun; 16(6):518-21. PubMed ID: 24607451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease.
    Rector A; Vermeire S; Thoelen I; Keyaerts E; Struyf F; Vlietinck R; Rutgeerts P; Van Ranst M
    Hum Genet; 2001 Mar; 108(3):190-3. PubMed ID: 11354628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.